1. Janež A, Guja C, Mitrakou A, et al. Insulin therapy in adults with type 1 diabetes mellitus: a narrative review. Diabetes Ther;2020;11(2):387-409. doi:10.1007/s13300-019-00743-7
2. Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers; 2017;3(1):17016. doi:10.1038/nrdp.2017.16
3. Norris JM, Johnson RK, Stene LC. Type 1 diabetes—early life origins and changing epidemiology. The Lancet Diabetes & Endocrinology; 2020;8(3):226-238. doi:10.1016/S2213-8587(19)30412-7
4. Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect; 2020;10(2):98-115. doi:10.34172/hpp.2020.18
5. Centre of Disease Prevention and Control https://www.spkc.gov.lv/lv/latvijas-veselibas-aprupes-statistikas-gadagramata-2015/3_sabiedribas_veseliba_2015_11.pdf (Last visited: 26 December 2021)
6. Pickup JC. Is insulin pump therapy effective in type 1 diabetes? Diabet Med; 2019;36(3):269-278. doi:10.1111/dme.13793
7. Campbell F, Lawton J, Rankin D, et al. Follow-Up Support for Effective type 1 Diabetes self-management (The FUSED Model): A systematic review and meta-ethnography of the barriers, facilitators and recommendations for sustaining self-management skills after attending a structured education programme. BMC Health Serv Res;2018;18(1):898. doi:10.1186/s12913-018-3655-z
8. Jeitler K, Horvath K, Berghold A, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia;2008;51(6):941-951. doi:10.1007/s00125-008-0974-3
9. Retnakaran R, Hochman J, DeVries JH, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care; 2004;27(11):2590-2596. doi:10.2337/diacare.27.11.2590
10. Benkhadra K, Alahdab F, Tamhane SU, McCoy RG, Prokop LJ, Murad MH. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis. Endocrine;2017;55(1):77-84. doi:10.1007/s12020-016-1039-x
11. Pouwer F, Hermanns N. Insulin therapy and quality of life. A review. Diabetes Metab Res Rev;2009;25(S1):S4-S10. doi:10.1002/dmrr.981
12. Cummins E, Royle P, Snaith A, et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess;2010;14(11). doi:10.3310/hta14110
13. Rechenberg K, Whittemore R, Grey M. Anxiety in youth with type 1 diabetes. Journal of Pediatric Nursing; 2017;32:64-71. doi:10.1016/j.pedn.2016.08.007
14. Alsaleh FM, Smith FJ, Taylor KM. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review: experiences of using insulin pumps. Journal of Clinical Pharmacy and Therapeutics;2012;37(2):140-147. doi:10.1111/j.1365-2710.2011.01283.x
15. Abualula NA, Jacobsen KH, Milligan RA, Rodan MF, Conn VS. Evaluating diabetes educational interventions with a skill development component in adolescents with type 1 diabetes: a systematic review focusing on quality of life. Diabetes Educ;2016;42(5):515-528. doi:10.1177/0145721716658356
16. Ross LJ, Neville KA. Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes. J Paediatr Child Health; 2019;55(6):718-722. doi:10.1111/jpc.14480
17. Thabit H, Hovorka R. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. Expert Opinion on Drug Delivery;2016;13(3):389-400. doi:10.1517/17425247.2016.1115013
18. http://www.diabets-asoc.lv/Anglu_valoda/izvelne.htm
19. http://diabetam.lv/2018/06/07/skaidrojums-par-kriterijiem-insulina-pumpja-terapijas-piemerosanai/ (Last visited: 26 December 2021)
20. Central Statistical Bureau (CSB) - https://lvportals.lv/dienaskartiba/323225-2019-gada-majsaimniecibu-riciba-esosie-ienakumi-pieauga-par-68-2020 (Last visited: 26 December 2021)
21. Salna I, Salna E, Pahirko L, Skrebinska S, Krikova R, Folkmane I, Pīrāgs V, Sokolovska JJ. Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes. Diabetes Complications; 2021;35(12):108072.
22. Digital Engagement Platforms, Longenesis Curator. Available: ttps://www.longenesis.com/curator; Longenesis Engage. Available: https://www.longenesis.com/engage
23. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation), OJ 2016 L 119/1.
24. IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp.
25. QSR International Pty Ltd. 2018; NVivo (Version 12), https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home
26. Valenzuela JM, Patino AM, McCullough J, et al. Insulin pump therapy and health-related quality of life in children and adolescents with type 1 diabetes. Journal of Pediatric Psychology;2006;31(6):650-660. doi:10.1093/jpepsy/jsj088
27. Al Shaikh A, Al Zahrani AM, Qari YH, et al. Quality of life in children with diabetes treated with insulin pump compared with multiple daily injections in tertiary care center. Clin Med Insights Endocrinol Diabetes;2020;13:117955142095907. doi:10.1177/1179551420959077
28. Müller-Godeffroy E, Treichel S, Wagner VM, on behalf of the German Working Group for Paediatric Pump Therapy. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus-a large-scale multicentre pilot study. Diabetic Medicine. 2009;26(5):493-501. doi:10.1111/j.1464-5491.2009.02707.x
29. Alqambar M. Impact of insulin pump use on disease control and quality of life in type I diabetes patients. Endocrinology & Metabolism International Journal; 2018;6(2). doi:10.15406/emij.2018.06.00169
30. Mesbah NI, Taha NAER, Rahme ZN, Sukkar FF, Omar DM. Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study. Med Princ Pract. 2020;29(3):255-261. doi:10.1159/000503705
31. Alvarado-Martel D, Velasco R, Sánchez-Hernández RM, Carrillo A, Nóvoa FJ, Wägner AM. Quality of life and type 1 diabetes: a study assessing patients’ perceptions and self-management needs. Patient Preference and Adherence; 2015:1315. doi:10.2147/PPA.S87310
32. Undén A-L, Elofsson S, Andréasson A, Hillered E, Eriksson I, Brismar K. Gender differences in self-rated health, quality of life, quality of care, and metabolic control in patients with diabetes. Gender Medicine; 2008;5(2):162-180.